The Investment Thesis Behind SynAIpse

The pain is universal. Physicians spend an average of 13 hours per week on prior authorizations alone (AMA, 2024). Administrative work consumes more clinician time than direct patient care at most independent practices. This is not a niche problem — every U.S. physician practice has a version of it.

The audience is large and underserved. Roughly 150,000 independent physician practices operate in the United States. Most have 1–10 providers and lack the administrative scale of integrated health systems. Existing RCM and practice-management vendors charge enterprise prices for enterprise features — and consolidation pressure is squeezing the segment annually.

The technology is finally viable. Large language models reached clinical-grade accuracy in 2024. Prior auth packets, denial appeals, coding suggestions, and patient summarization — all previously requiring human judgment — can now be generated, reviewed, and submitted at machine speed with physician oversight.

The regulation is tailwind. CMS Final Rule 0057-F (effective January 2026) requires payers to expose APIs for automated prior authorization submission and status tracking. The infrastructure for AI-driven PA is being built into the payer ecosystem itself — making the timing of automation tools materially better than at any prior moment.

Healthcare-AI startups fail at one of three places: they don't understand clinical workflow, they can't reach physicians, or they can't earn the trust to handle PHI. Synaipse is structurally protected against each.

Clinical depth no tech-only competitor has. Co-Founders Soliman Oushy, MD and Robert F. James, MD are practicing neurosurgeons at Mayfield Brain & Spine in Cincinnati. They live the prior-auth grind, the appeals queue, the patient-on-hold problem — daily. The product is tested every clinical week. Tech-only founders can shadow physicians; they can't be them.

Engineering depth physicians don't usually have. Co-Founder & CTO Charles Greenman has rebuilt HIPAA-compliant clinical platforms serving 300+ practitioners (12x performance gain) and shipped production AI agents on Amazon Bedrock and LangGraph. The technical and the clinical sit at the same founders' table.

Distribution through physician trust. Independent practices buy on peer recommendation, not on cold outreach. Physician-founded companies enter the market through clinical networks, conference floors, and shared training programs. We don't need a sales team to win the first hundred practices — we need our founders' phones.

Compounding data advantage. Each new practice expands our coverage of payer rules, denial patterns, and EHR-integration depth. Future customers benefit from prior customers' data — a network effect competitors won't replicate without time and customer count.